retatrutide fatty liver study Triple hormone receptor agonist for metabolic dysfunction-associated steatotic disease: a randomized phase 2a trial retatrutide nafld 🧬 BREAKTHROUGH IN

That was such a great conversation with Ashley

IGF-1 Mediation Increased GH stimulates hepatic IGF-1 production, which mediates downstream effects including fat metabolism, tissue repair, and cellular regeneration

GHK-Cu downregulates inflammatory cytokines, reduces the activity of pro-inflammatory signaling cascades, and modulates p38 MAPK in a way that reduces inflammatory response without suppressing the growth factor signaling needed for tissue repair

Most people lead with Retatrutide so the body adjusts to the dominant compound, then add Cagrilintide once that rhythm is comfortable

It is also essential to understand that higher doses are not automatically better for every patient